Latest News

 Filter by Provider

Occidental Petroleum offers an annual dividend yield of 2.38% (96 cents a year). How can investors capitalize and pocket $500 monthly?

The Oracle of Omaha still has a great deal of money on the sidelines, unfazed by the stock market's ongoing gains.

Fluor Corp (FLR) reported Q3 2025 results, with adjusted EPS beating estimates and revenue missing. Backlog down 10% but new awards up 21%.

Aurinia Pharmaceuticals (AUPH) exemplifies a top growth stock, showing explosive earnings growth, soaring cash flow, and consistent earnings surprises.

Apple, Palo Alto and Western Union are among the companies mentioned on the latest edition of CNBC's "Final Trades."

Gold holds firm as political risks, weak jobs data, and legal uncertainty drive safe-haven demand.

Cramer recommends owning TJX and not selling it. "TJX is really, really strong. It's what works in a bad market," he added.

Modine Manufacturing (MOD) is a high-growth stock in thermal management with strong fundamentals and a bullish technical setup poised for a potential breakout.

Check out the companies making headlines this week:

Keeping cash at home might feel smart, but it's riskier than it looks. Here's where to actually keep it working for you.

The feast that saw obesity-tied stocks skyrocket in 2024 is over. Investors' appetite for weight-loss drugs has waned.

Alphabet had an October to remember.

The USD/JPY pair retreated to 153.10 on Friday, with the yen retaining a portion of its recent gains amid a flight to safety.

Whale Watching: Investment Manager Loads the Boat With $16.3 Million Worth of Chemicals Stock

Wells Fargo lifted its price target on Expedia shares to $272 from $212.

Jamie Dimon reiterated his prediction that artificial intelligence (AI) will lead to a shorter workweek in the developed world.

In early September, Opendoor named Shopify’s Chief Operating Officer, Nejatian, as the company’s new CEO.

AdvanSix Inc. reported a steep decline in Q3 earnings but beat revenue estimates. The company also announced a quarterly dividend.

Pelthos Therapeutics acquires U.S. rights to Xepi Cream and raises $18 million to fund its relaunch and expand dermatology product offerings.

Fluor Corporation increased its EBITDA and EPS outlook for FY2025.

Crinetics Pharmaceuticals (CRNX) shows strong technical momentum and a high-quality consolidation setup, signaling a potential breakout opportunity for traders.

Earnings season in November 2025 has featured a mix of strong revenue growth and some profit outlook caution, leading to volatility.

Sysco stock has trailed behind the broader market over the past year, but analysts remain fairly bullish about its prospects.

Digital ad verification company DoubleVerify (NYSE:DV) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 11.2% year on year to $188.6 million. Next quarter’s revenue guidance of $209 million underwhelmed, coming in 0.9% below analysts’ estimates. Its non-GAAP profit of $0.22 per share was 17.4% below analysts’ consensus estimates.

Is the big post-earnings jump a sign of more upside ahead, or just temporary relief?

While D.R. Horton has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

DAVE stock shows a powerful Minervini Trend Template setup, backed by explosive 14,033% earnings growth, signaling high-potential momentum.

The FTSE 100 opened softer, trailing broader regional indices.

Robinhood doubles revenue but shares drop 6% after CFO Jason Warnick announces retirement, raising concerns over leadership stability.

The S&P 500 nuclear leader also narrowed its full-year EPS range.

Third-quarter GDP growth disappointed at 4.0% YoY, dragged down by weak investment and softer government spending, while exports provided temporary support.

SABESP (SBS) stock aligns with the CAN SLIM method, showing strong earnings growth, high profitability, and excellent technical momentum for potential gains.

Real estate brokerage and services firm Marcus & Millichap (NYSE:MMI) met Wall Streets revenue expectations in Q3 CY2025, with sales up 15.1% year on year to $193.9 million. Its GAAP profit of $0.01 per share was 80% below analysts’ consensus estimates.

Constellation Energy (CEG) missed Q3 2025 earnings estimates, sending shares down. Despite the miss, the company reported strong operational growth and narrowed its full-year guidance.

Atmus Filtration (ATMU) Q3 2025 earnings beat estimates, driving a stock surge. The company raised its full-year guidance after completing its separation from Cummins.

Nvidia stock is set to deliver strong returns for the third consecutive year. It should continue its rally into 2026 as well, though the intensity might not be as fierce as we have seen since 2023.

AI applications are driving growth at this exciting technology company.

Rapid Micro Biosystems posts mixed Q3 2025 results, missing estimates but raising full-year guidance after securing a major new customer order.

Gyre Therapeutics Q3 2025: A mixed quarter with a significant earnings beat and strong cash position, but revenue missed estimates and full-year guidance was lowered.

MarketAxess Q3 2025 earnings beat EPS estimates but revenue slightly missed. The stock rose pre-market as profitability impressed despite softer U.S. credit revenue.

Claritev (CTEV) reports Q3 2025 results with a revenue beat and improved guidance, but a wider-than-expected net loss. The stock surged on the news.

AirSculpt Q3 2025 earnings miss estimates with a 17.8% revenue drop and a widened net loss, causing a 21% stock decline.